The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.
Open Access
- 1 March 1979
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 149 (3), 732-744
- https://doi.org/10.1084/jem.149.3.732
Abstract
Subcutaneous implantation of DBA/2-derived L5178Y cells into DBA/2 mice followed 10 d later by nodule excision protected 100% of mice from the rapid outgrowth of an intraperitoneal challenge of L5178Y cells given 7 d postexcision. Challenged mice remained clinically normal for 48--250 d before onset of an ultimately fatal tumor outgrowth. The numbers of L5178Y cells in the peritoneal cavity increased logarithmically for 4 d after challenge and then declined to low but detectable levels which persisted throughout the clinically normal period. Cells active in 18-h in vitro cytolytic assays against 51Cr-labeled L5178Y target cells were found in the peritoneal cavity. The effector cells were determined to be Thy1.2 positive. Their activity was tumor specific and reached peak levels 4 d after tumor challenge and then gradually declined to undectable levels during the following 70 d. Tumor emergence occurred most frequently during the period when CMC activity was no longer demonstrable in the remaining clinically normal mice. A transient peak of low level cytophilic antitumor antibody was detected about 30 d after tumor cell challenge. The temporal associations between the numbers of tumor cells and the levels of cell-mediated lysis against L5178Y cells indicate the importance of the cell-mediated cytolysis response in limiting initial tumor outgrowth and suggest its role as one of the factors responsible for long-term tumor suppression during tumor dormancy.Keywords
This publication has 32 references indexed in Scilit:
- The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.The Journal of Experimental Medicine, 1979
- Immunity to Lymphoid Tumors Induced in Syngeneic Mice by Immunization with Mitomycin C-Treated CellsThe Journal of Immunology, 1977
- T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.The Journal of Experimental Medicine, 1977
- CHARACTERIZATION OF SUPPRESSIVE IMMUNOGLOBULIN-BINDING FACTOR (IBF) .1. PRODUCTION OF IBF BY A THETA-POSITIVE LYMPHOMA (L-5178-Y)1977
- DURATION OF DORMANT STATE IN AN ESTABLISHED CELL LINE OF HUMAN HEMATOPOIETIC CELLS1977
- NEW CONCEPT OF TISSUE AND TUMOR-CELL PROLIFERATION1977
- IMMUNOGENICITY OF TUMOR ANTIGENSAnnals of the New York Academy of Sciences, 1976
- Chronic Infusion of Tritiated Thymidine into Mice with TumorsScience, 1962
- Experimental Evidence in Support of the Dormant Tumor CellScience, 1959
- The Dormant Cancer CellBMJ, 1954